Laboratory report
BPC-157 + TB-500
Sample: BPC-157 10 mg + TB-500 10 mg
- Batch
- SP0330-001
- Analysis date
- 22 April 2026
This report does not include peptide purity testing.
Read original reportQuality & documentation
Look closer.
Know more.
Read the original reports. Match the details.
Make your research decisions with clear information.
The documents below are published laboratory reports for specific samples. They do not establish the composition, purity, or sterility of every product or a different lot. Confirm that the product, labeled amount, and current lot match before ordering.
Published laboratory reports.
Original documents · JanoshikLaboratory report
KPV
Sample: KPV 10 mg
- Batch
- 2026.04.28
- Analysis date
- 25 May 2026
Reported KPV content: 11.07 mg in the tested sample.
Read original reportLaboratory report
Tirzepatide
Sample: Tirze 30 mg
- Batch
- 2026.04.28
- Analysis date
- 25 May 2026
Reported tirzepatide content: 30.44 mg in the tested sample.
Read original reportHistorical sample reports.
These sample amounts differ from the current product listings. They are presented with their original sample labels for transparency.
Historical sample
Retatrutide · 20 mg sample
Historical 20 mg sample. This is not a matching report for the current GLP3-Reta 30 mg listing. Request the current report before ordering.
Batch 2026.04.28 · 25 May 2026 · 99.621% reported purityHistorical sample
Tesamorelin · 10 mg sample
Historical 10 mg sample. This is not a matching report for the current Tesamorelin 20 mg listing. Request the current report before ordering.
Batch 2026.04.28 · 25 May 2026 · 98.114% reported purityNeed the current lot report?
Tell us the product and labeled amount, or include your order number.
Laboratory verification instructions are printed inside each report. A purity percentage is not a statement of suitability for human or animal use. Read our research-use information.